Dr Russell Lee Whatley, OD | |
518 Avenue A, Opelika, AL 36801-5064 | |
(334) 745-3112 | |
(334) 745-8751 |
Full Name | Dr Russell Lee Whatley |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 34 Years |
Location | 518 Avenue A, Opelika, Alabama |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740358076 | NPI | - | NPPES |
OT42627 | Other | AL | UNITED HEALTH CARE |
009934524 | Medicaid | AL | |
51531835 | Other | AL | BLUE CROSS AND BLUE SHIEL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | S-720-TA-192 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern Eye Care Associates, Llc | 8123374469 | 3 |
News Archive
Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug.
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis.
› Verified 5 days ago
Provider Name | Southern Eye Care Associates, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1710481387 PECOS PAC ID: 8123374469 Enrollment ID: O20180628003203 |
News Archive
Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug.
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Russell Lee Whatley, OD 518 Avenue A, Opelika, AL 36801-5064 Ph: (334) 745-3112 | Dr Russell Lee Whatley, OD 518 Avenue A, Opelika, AL 36801-5064 Ph: (334) 745-3112 |
News Archive
Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.
Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.
A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug.
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis.
› Verified 5 days ago
Dr. Lindsey George, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2111 Tiger Town Pkwy, Opelika, AL 36801 Phone: 334-528-9020 | |
Eamc Eye Clinic, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 122 N 20th St Bldg 26, Opelika, AL 36801 Phone: 334-749-1486 | |
Dr. Charles Kennon Berry Sr., O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2900 Pepperell Parkway, Vision Center Store 0355, Opelika, AL 36801 Phone: 334-745-0980 Fax: 334-745-6211 | |
Whatley Eye Care, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 518 Avenue A, Opelika, AL 36801 Phone: 334-745-3112 Fax: 334-745-8751 | |
The Optical Shop Optometrist Medicare: Medicare Enrolled Practice Location: 2496 Enterprise Dr, Opelika, AL 36801 Phone: 334-705-8803 | |
Whatley Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 518 Avenue A, Opelika, AL 36801 Phone: 334-745-3112 Fax: 334-745-8751 | |
Auburn Lasik & Eye Institute, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3021 Frederick Rd, Ste 4, Opelika, AL 36801 Phone: 334-705-8803 Fax: 334-705-8643 |